Panjiva Daily: Black, grey and green swan risks in 2020; the phase 1 pharma harvest — Panjiva
Más

Panjiva_research_logo

Panjiva Daily: Black, grey and green swan risks in 2020; the phase 1 pharma harvest

Global 963 Panjiva Daily 402

Global supply chains face a wide range of low-probability, high impact risks in 2020 raising from conflict in Asia to increased emissions regulation. China’s pharmaceutical single buyer program may be key to the phase 1 trade deal with the U.S. Also: pharma harvest from phase 1 deal may be transshipments; Dollar General, Greif may bag bargains as China bans single-use plastics; new normal means same problems as Los Angeles loses out from tariffs; Macron, Trump talks might have delayed first shots in EU-U.S. trade battle; and Trump sets out the stall; Also: pharma harvest from phase 1 dea...

PANJIVA RESEARCH is a service provided by Panjiva, Inc. ("Panjiva") to relevant global subscribers, and are deemed to be Panjiva "Services" subject to the Panjiva Terms & Conditions of Use. Information contained within or made available via the Services is for informational purposes only and nothing in the Services shall constitute or be construed as an offering of financial instruments, or as investment advice or recommendations by Panjiva, Inc. or its affiliates of an investment strategy or whether to "buy", "sell" or "hold" an investment. The Services may include views and commentary about customers of Panjiva. No aspect of the Services is based on consideration of your individual circumstances, and you should determine on your own whether you agree with the information contained within or made available via the Services. Employees involved in Panjiva Research may hold positions in securities analyzed or discussed in the Services. Panjiva does not make any express or implied warranties, representations, endorsements or conditions with respect to the Services and the information contained within or made available via the Services, including without limitation, warranties as to the usefulness, completeness, accuracy, currentness, reliability or sufficiency of any information (including, without limitation, conclusions, statements, opinions, estimates, forecasts or projections of any kind) and expressly disclaims any implied warranties. Neither this disclaimer nor any of its contents may be forwarded or redistributed without the prior written consent of Panjiva. © 2020 S&P Global. All Rights Reserved.